Prevalence and characteristics of HPV-driven oropharyngeal cancer in France - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancer Epidemiology Année : 2019

Prevalence and characteristics of HPV-driven oropharyngeal cancer in France

(1, 2) , (3) , (4) , (5) , (6) , (7) , (8) , (9, 10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (18, 19)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Georges Noel
  • Fonction : Auteur
  • PersonId : 948509

Résumé

Background: France has one of the highest incidence of head and neck cancers in Europe. Despite this, the epidemiological impact of high-risk human papilloma virus (HR-HPV) remains poorly investigated. Methods: we prospective assessed the proportion of oropharyngeal cancers due to HR-HPV in 15 hospitals throughout France. HPV-status was determined by p16-immunohistochemistry, and by detection of HPV-DNA using in situ hybridization. Cancers were classified as HPV-driven if both p16-immunohistochemistry and HPV-DNA assays were positive. Demographical and clinical features were recorded. Results: 291 patients with palatine-tonsil or tongue-base cancers were recruited from March-2011 to July-2012. Of these, 43.1% of samples were p16-positive and 37.7% were positive for both p16 and HPV-DNA. Prognosis was significantly better in patients with HPV-driven cancers, with smoking negatively impacting patients' oncological outcomes. Conclusion: in France, more than a third of tonsillar and tongue base cancers are HPV-driven. More research concerning the evolution of HPV-driven cancers over time is needed.
Fichier non déposé

Dates et versions

hal-02771653 , version 1 (04-06-2020)

Identifiants

Citer

Haitham Mirghani, Carine Bellera, Jessy Delaye, Gilles Dolivet, Nicolas Fakhry, et al.. Prevalence and characteristics of HPV-driven oropharyngeal cancer in France. Cancer Epidemiology, 2019, 61, pp.89-94. ⟨10.1016/j.canep.2019.05.007⟩. ⟨hal-02771653⟩
116 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More